Introductory Chapter: Transgenics—Crops Tailored for Novel Traits by Khan, Muhammad Sarwar & Malik, Kauser Abdulla
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors




the world’s leading publisher of
Open Access books






Introductory Chapter: Transgenics—Crops Tailored for
Novel Traits
Muhammad Sarwar Khan and Kauser Abdulla Malik
Additional information is available at the end of the chapter
http://dx.doi.org/10.5772/intechopen.81372
© 2016 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons 
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, 
distribution, and reproduction in any medium, provided the original work is properly cited. 
Muhammad Sarwar Khan 
and Kauser Abdulla Malik
Additional information is available at the end of the chapter
1. Introduction
Transgenic crops are referred to as the genetically engineered crops. Traits, otherwise impos-
sible to introduce by conventional approaches, are tailored using genetic manipulations and 
transformation approaches. Among traits is the introduction of agronomic, pathological, ento-
mological, nutritional, therapeutic-, and vaccine-related characters in plants. The chapter covers 
state-of-the-art advancements in this rapidly developing area of transgenic technology and the 
technology for the food and health security mainly of poor populace in the developing countries.
This era has seen an explosive growth in population and urbanization, leading to an immense 
loss of agricultural land; therefore, the food security, especially which of poor populace, is of 
foremost importance. According to an estimate, this requires approximately 70% increment 
in food production by 2050. Since the 1990s, the introduction of insect resistance and herbi-
cide tolerance into transgenic crops has increased the yield tremendously, benefiting farmers 
worldwide. Though production is increased by addressing problems of yield losses using 
transgenic technology, malnutrition is still one of the biggest challenges, demanding fortifica-
tion of grains. Since nutrition is one of the main factors in maintaining a healthy lifestyle 
and meeting requirements of food security, several national nutrition surveys conducted in 
various countries have provided an avenue for governments to assess malnutrition problems 
across populations. Micronutrient deficiencies have been termed as the cause of “hidden 
hunger.” Iron-fortified products are the prime examples of it. Pyramiding genes that encode 
provitamin A, transgenically or naturally, in crops like rice [1], potatoes [2], and maize [3, 4] 
have made these crops a rich source of provitamin A. In addition to adding nutritional ele-
ments in crops, the transgenic technology has led the scientists to tailor medicinal traits, for 
example, therapeutic [5, 6] and antigen proteins [7].
© 2018 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative
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Transgenic crops are developed in routine to express agricultural and medicinal traits, but 
it is very important to discuss the technologies used to develop them. Nuclear transforma-
tion is more successful in tailoring agricultural traits in crops (Figure 1), though it remained 
unfruitful in few genotypes like upland cotton in the Indo-Pak subcontinent, the reason being 
these genotypes are recalcitrant to regeneration from single cell, despite several crosses were 
made between genotypes to improve the regeneration potential, while chloroplast trans-
formation is distinctly effective to tailor medicinal traits (Figure 2) [5, 6], the reason being 
nutraceutical, pharmaceutical, and antigenic proteins are required to be accumulated in 
exceptionally high amounts with bona fide structures. Chloroplasts are polyploid at organel-
lar and genome levels and provide natural gene containment [8]; hence, they are preferred 
Figure 1. Transgenics predominantly for agronomic traits. Panel A explains the transformation steps involved in the 
development of transgenics. Panel B shows integration of transgene into the nuclear genome of crops via Agrobacterium-
mediated or ballistic transformation approaches where transformation vector is either bombarded or cloned between left 
and right borders of a plasmid vector and multiplication using suitable Agrobacterium strain.
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to express health-related traits rather agricultural. Plastid transformation though is achieved 
in wheat [9], rice [10], and sugarcane, but it is reproducible only in rice [11], yet transgenic 
plants remain heteroplasmic.
Figure 2. Transgenics predominantly for health-related traits. Panel A explains main steps involved in the development 
of transgenic chloroplasts to express transgenes that encode novel proteins to be used as nutraceuticals, therapeutics or 
vaccines. Panel B explains how a transgene from a transformation vector is integrated into the plastome via homologous 
recombination events to accumulate proteins to high levels with bona fide structures.
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2. Developing transgenics: state-of-the-art strategies
A plant cell is blessed with three major organelles with their own genomes, namely, nucleus, 
chloroplast, and mitochondria. Of these three, two genomes are routinely manipulated to 
incorporate new traits in cultivated plants. There are a number of approaches to transfer and 
introduce genes into the plant genome, depending upon the choice of explant to be used in 
transformation experiments, for example, Agrobacterium-mediated gene transfer, gene gun, 
agro-infiltration, sonication, and polyethylene glycol treatment. Of these, Agrobacterium-
mediated and gene gun methods are most commonly used approaches to develop transgenic 
plants. For nuclear transformation, Agrobacterium method is more successful than particle 
bombardment as a more number of transformed shoots can be recovered from the same num-
ber of explant.
Genetic transformation process involves a number of steps, including selection of a gene that 
confers resistance to a particular antibiotic for selection and screening purposes, isolation of a 
trait-encoding gene, choice of promoters and terminating sequences to control the expression 
of the gene or genes, choice of explant, and an artificial medium to support explant to regen-
erate into a complete shoot. For selection and screening, usually two types of markers are 
used: (1) selectable marker and (2) visual marker [10, 12–14]. Selectable marker could be lethal 
or nonlethal in nature. Nuclear genome transformation is carried out using lethal markers. 
Regenerated shoots are normally hemi- or heterozygous and need either further purification 
of transgenome using selection medium or through selfing depending upon the crop used.
The second genome is the chloroplast genome, the plastome that has been modified in 
a number of plant species, including model, crop, and tree plants. Plastome is a double-
stranded DNA molecule of 152 (Cinnamomum campohra) – 218 kb (Pelargonium) size [15, 16]. 
Approximately, 120 genes in various plant species are encoded by the plastome [17]. It looks 
like that most of the ancestral genes have either been lost during evolution or transferred to 
the nucleus. A mature mesophyll cell contains up to 100 chloroplasts, and each chloroplast 
contains 100 plastome copies; therefore, the ploidy number of plastome per cell reaches up 
to 10,000 copies. Furthermore, this number is doubled for genes that are located in inverted 
repeat regions of the plastome [17].
When transforming a chloroplast, a universal antibiotic cannot be used given that different 
plants have variable sensitivity to selective agents; therefore, recovery of the transplastomic 
shoots is dependent on two things: (1) choice of the selective agent to be used and (2) the 
concentration of the selective agent that allows regeneration and development of shoots from 
the transformed cells while killing the non-transformed cells. For example, spectinomycin is 
used to select transformed cells on selection medium from tobacco, lettuce, tomato, potato, 
cabbage, oil rape seed, and carrot. However, several monocots, including rice and sugarcane, 
are naturally resistant to spectinomycin; therefore, streptomycin-containing medium was 
used for carrying out selection for transplastomic lines.
Initially, only few copies of the plastid genome are transformed and maintained under con-
tinuous selection pressure. However, stable lines with uniformly transformed genome cop-
ies are recovered on selection medium through a repeated cycle of regeneration [6]. During 
the period, the wild-type and the transgenic plastids and their genomes gradually sort out; 
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thereby, chimeric sectors, carrying wild-type or transgenic plastids, appear in leaves of regen-
erated shoots. Due to phenotypic masking by the transformed cells, both transgenic and wild-
type cells in a chimeric shoot look green in color [6], indicating that antibiotic resistance is not 
cell autonomous. However, both wild-type and transformed sectors are identifiable using 
green fluorescent protein (GFP). This visual marker allows visual detection of the fluoresc-
ing transproteins because they produce green fluorescence upon illumination with blue or 
ultraviolet (UV) light [18, 6].
3. Transgenics for agricultural traits
3.1. Transgenics to improve crop production
Plants on earth synthesize their food by themselves, owing to harbor solar energy conversion 
and several other chemical reactions in their cells. One of the reactions carried out in plants 
is carbon fixation during a process, namely, photosynthesis. During photosynthesis Rubisco 
catalyzes the inefficient carbon fixation, reviewed extensively elsewhere [19, 20]. This raises 
a question why carbon fixation during photosynthesis is rate limiting. Major reasons are as 
follows: first, Rubisco’s rate of catalysis is much low, and, second, it has to compete with 
a nonproductive reaction, oxygenation [21], depending upon the relative concentration of 
carbon dioxide and oxygen, as well as on temperature. Carboxylation results in CO
2
 fixation. 
Therefore, plant growth and yield can be improved by two ways: (1) by increasing photosyn-
thesis and (2) by reducing photorespiration.
A number of examples are available in the literature, reporting different versions of Rubisco 
that would improve photosynthesis [22], but considerable success has not been achieved yet. 
Introducing C
4
 pathway in C
3
 plants appears to be more promising, but due to the leakage 
of gases, the advantages of concentrating carbon dioxide in the chloroplasts of C
3
 plants are 
objectionable [23]. Glycolate catabolic pathway was introduced in chloroplasts for allevia-
tion of photorespiratory losses in Arabidopsis thaliana. Photosynthesis is markedly increased 
in this engineered pathway, thereby widening the applicability of the technique to cereals, for 
example, wheat and rice, described in detail elsewhere [24].
Developing chlorophyll in the dark, and chloroplasts that are competent for photosynthesis 
upon exposure to light, is another promising technique that can be implied to improve the 
photosynthesis in plants [25, 26]. In a study, chlB gene from Pinus thunbergii was introduced 
into the plastome of Nicotiana tabacum [27]. Transgenic plants when shifted to light from dark 
in early development of chlorophyll pigments were observed in leaves of transgenic com-
pared to wild-type plants. This helps us to understand the molecular biology of transgenic 
angiosperms. Another effort is underway to introduce C
4
 pathway in rice, a C
3
 plant [28], 
using various techniques.
3.2. Transgenics for weed management
Weeds compete with crops for food, thereby lowering the crop yield and affecting farmers. 
There are two types of herbicides, (1) selective in nature and (2) used before and after emer-
gence of plants from seeds, and are specific to leaf morphology.
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A pioneering concept to engineer a crop for herbicide tolerance was developed in the 1980s 
[29] when it was observed that few herbicides kill plants by blocking photosynthetic elec-
tron transport. For example, triazine herbicides bind to a photosystem-II protein (D1) in the 
chloroplasts that appeared to be the first molecular target to develop a commercial herbicide 
[30]. However, tolerance to herbicides in transgenic plants is considered the best approach 
in weed control in crops. Glyphosate is a nonselective broad-spectrum herbicide that kills 
narrow-leaf grasses and broad-leaf weeds. Glyphosate competitively inhibits 5-enol-pyruvyl 
shikimate-3-phosphate synthase (EPSP) in the amino acid biosynthetic pathway. This proves 
to be a standard strategy to overcome the problem of herbicide selectivity. Yet, this strategy 
raises the concern of gene transfer to other plants or weeds.
An antibiotic bialaphos inhibits glutamine synthetase (GS) upon removal of alanine residues 
in the nitrogen assimilation pathway; resultantly, accumulation of toxic levels of ammonia in 
both bacteria and plant cells occurs. This antibiotic was used as an herbicide that appeared to 
be nonselective in nature. In two different studies, transgenic tobacco plants exhibited field-
level tolerance to phosphinothricin (PPT) when bar was expressing from chloroplast genome 
[31, 32]. Further, development of glufosinate-resistant traits has been reported worldwide in 
corn, soybean, and cotton until now. The trait has also been developed by Khan and his team 
in sugarcane, and the transgenic plants were tolerant to BASTA [33]. The extensive and con-
tinuous use of a single herbicide should be avoided to exclude the possibilities of resistance 
development in plants, and precautionary measures should be taken to safeguard human 
health.
3.3. Transgenics for insect resistance
Engineering plant genomes for useful traits leads toward sustainable agriculture. Among use-
ful traits, resistance against insects is developed by using Cry proteins from Bacillus thuringi-
ensis (Bt). Bacillus thuringiensis is a soilborne bacterium, having crystal (Cry) proteins in the 
cytoplasm of the cells at sporulating stage. These proteins are toxic to some chewing and 
sucking insects.
Genes encoding Cry proteins have been expressed in a number of crops worldwide to con-
trol major pests. This has reduced the pesticide usage and has lowered the production costs 
of crops. First, transgenic crops developed were corn and cotton that expressed cry1Ab and 
cry1Ac genes, respectively [34]. Afterward, other crops including soybean, maize, cotton, 
canola, squash, papaya, tomato, sugar beet, and sugarcane were transformed using Bt genes 
to control insects. Almost all global biotech crop area is because of soybean, corn, cotton, and 
canola crops [35]. Since the first commercial cultivation of GM crops in 1996, farmers (16.7 
million) from 29 countries cultivated 160 million hectares of biotech crops in 2011. Out of this 
number, about 90% were small and resource poor farmers belonging to developing countries. 
The United States and Brazil were major producers who adopted GM crops.
In Pakistan, first indigenously developed transgenic crop was sugarcane, carrying cry1Ab 
gene that was approved by the Technical Advisory and National Biosafety Committees after 
the approval of biosafety rules and guidelines in 2005. Developed sugarcane plants carry 
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Bt toxin only in green tops with no residues in the juice [36]. Lately, a different version of 
the cry1Ab gene was again used to develop transgenic sugarcane, and similar results were 
obtained.
3.4. Transgenics for pathogen resistance
Plant pathogens are damaging plants and causing yield losses exceptionally; it is therefore 
highly desirable to develop transgenics that would be resistant to pathogenic bacteria and 
fungi. There are a number of examples available in literature where pathogens have been 
targeted to control diseases in plants. Arrieta and colleagues in 1996 reported co-expression 
of genes encoding glucanase- and thaumitin-like proteins, and a low level of fungal infec-
tion was observed [37]. In other studies when snakin-1 gene was overexpressed trans-
genically, an enhanced resistance to Rhizoctonia solani and Erwinia carotovora was observed. 
Similarly, chitinase gene from Streptomyces griseus showed resistance against Alternaria solani, 
while expression of mycoparasitic chitinase and glucanase enzymes developed improved 
resistance to Rhizoctonia solani. Five novel thionin genes were isolated from plants belong-
ing to the Brassicaceae family, and when expressed transgenically in potato, a high-degree 
resistance to gray mold (Botrytis cinerea) was observed [38]. Literature review suggests that 
 broad- spectrum resistance could be attained in valuable plant species through transgenic 
technology. Mycoparasites can be controlled using glucanases, chitinases, proteases, cellu-
lases, kinases, and certain antibiotics.
Amphipathic peptides such as magainin are known to control microbe infections; Daniell and 
his colleagues expressed MSI-99 in chloroplasts of tobacco and reported a varied degree resis-
tance to microbes [39] with no changes in growth and development of the transgenic plants 
compared to wild-type plants. But using such genes in crops warrants extensive biosafety 
studies.
4. Transgenics for medicinal traits
4.1. Transgenics for nutraceuticals
One of the items on the wish list of biotechnologists is to engineer genomes of plants to tailor 
high-value traits other than agronomic, pathological, and entomological in nature. Among 
high-value traits are the introduction of nutrition and related characters. “Nutraceuticals” is 
a portmanteau of “nutrition” and “pharmaceuticals”; hence, the word implies that nutraceu-
ticals are products regulated as medicine, food ingredients, and dietary supplements. These 
products not only provide protection against various diseases caused due to the deficiency 
of the nutrients but also have physiological benefits. Traditionally, nutraceuticals have been 
employed in the form of medicinal plants, etc., but in this modern era, nutraceuticals are 
being used in a variety of perspectives, such as nutrition and medicine. Iron-fortified products 
are the prime examples of it. Addition of iron-containing compounds during the grinding 
of wheat, otherwise deficient in iron, protects the wheat-dependant populace from diseases 
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caused by deficiency such as iron-deficiency anemias, etc. Iron fortification of wheat has 
been proven transgenically by expressing phytase gene (phyA) from Aspergillus japonicas [40]. 
In situ degradation of phytates in the seed endosperm is considered desirable in order to 
increase bioavailability of micronutrients [40].
Golden rice and provitamin A-fortified maize are crops that have caught interest of nutri-
tionists globally. Provitamin A deficiency that results in night blindness in masses may be 
addressed through genetic improvement of crops like maize. In a study where single-cross 
maize yellow hybrids were evaluated for carotenoid contents [3] since biofortification of 
maize, endosperm is found to be the most convenient solution addressing its deficiency. 
Hence, improved contents of provitamin A carotenoids in maize may help Pakistani populace 
to alleviate the subclinical symptoms of vitamin A deficiency [4].
Perhaps, the most researched aspects of nutraceuticals are their use in medicine, to cure a 
variety of diseases such as cancer, osteoarthritis, cardiovascular disorders, etc. Over the years, 
several plants have been shown to contain compounds which, if incorporated into lifestyle 
early on, reduce the risk of cancer by as much as 33%. For example, blue maize has been found 
to be an effective nutraceutical in prevention of several types of cancers, such as colon cancer, 
etc. [41].
This era of rapid urbanization has seen an emerging trend of expressing many medicinal 
and nutritional traits into other food crops transgenically. Although several people have 
shown their concerns as to its biosafety, such drawbacks have not been reported to this date. 
Chloroplast transformation addresses biosafety issues as chloroplasts are not transmitted 
through pollens in most cultivated plants. Hence, the transgenics are a promising way for-
ward to develop cost-effective nutraceuticals.
4.1.1. Transgenics for therapeutics
A number of pharmaceutical proteins have been synthesized exploiting plant genetic systems 
with overriding impact on conventional approaches used to manufacture pharmaceuticals. 
Some advantages of using plant system are low cost of production of pharmaceuticals and 
their processing. Commercial-scale production in bringing therapeutics to the clinic has 
been observed in the last 6–7 years. Manufacturing facilities of different capacities have been 
constructed in addition to the development of plant-made pharmaceuticals to meet current 
manufacturing standards [42]. Large Scale Biology Corporation (LSBC) in Owensboro, KY, 
USA, has designed the first manufacturing facility that plant virus transient expression sys-
tem was developed to meet the current good manufacturing practice [43, 44].
However, synthesizing pharmaceuticals in plants by engineering the chloroplast genome is 
more advantageous as explained elsewhere in this chapter; therefore, attempts have been 
made to express different pharmaceuticals proteins. For example, interferons α2 and 5 were 
expressed from tobacco chloroplasts [5, 6]. In these studies the interferon α2 and 5 genes were 
synthesized and expressed. It was observed that fully expanded mature leaves contained 
high levels of interferon hen compared to young and senescence leaves; however, expression 
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levels were very low because of a mutation in the critical region of the promoter during 
synthesis. Other examples of therapeutic expression are human serum albumin (HSA) that 
was expressed between 0.02 and 11.1%, depending upon the regulatory sequences used [45], 
oral and injectable insulin [46], HIV inhibitor cyanovirin [47], TGFb3 [48], and thioredoxins 
from plastids as modulators of recombinant therapeutic protein production [49]. Recently, 
different companies and foundations like the Bill and Melinda Gates Foundation or Juvenile 
Diabetes Research Foundation are undertaking well to advance such developments from labs 
to the clinics.
4.2. Transgenics for antigenic proteins (vaccines)
Vaccination is an efficient strategy to control viral infections in both human and animal spe-
cies. Different expression systems, having their own merits and demerits, are being used to 
produce recombinant vaccines. An ideal system would be that allows producing the desired 
functional product cost-effectively. Plant-based expression strategies encouraged biotech-
nologists to use this system to produce vaccines for both humans and animals. Moreover, 
plant system-derived subunit vaccines are heat stable, bio-encapsulated, and easy to scale up.
Oral vaccine term was introduced and extensively pursued after the successful expression 
of HBsAg in plants and recovery of the antigen as viruslike particles [50]. Interestingly, the 
antigen has the same properties as produced in yeast. Later on, the binding subunit of E. coli 
enterotoxin (LTB) and the capsid protein of norovirus genotype, which formed viruslike par-
ticles (NV-VLP), was expressed in plants that triggered mucosal immunization response in 
animals, hence, based on the data on approval clinical trials was obtained [7]. Diverse antigenic 
proteins were expressed in vegetable and fruit crops, and animal trials were successfully con-
ducted. Plant species used are alfalfa, carrot, lettuce, tomato, potato, maize, soya bean, rice, 
and banana [51].
Development of an efficient plant-based system to express human antigenic proteins suc-
cessfully has prompted its application to vaccinate livestock. Different attempts have been 
made by different research groups to address various diseases of livestock caused by viruses 
to increase the production in a cost-effective manner. Some of the examples are foot-and-
mouth disease virus (FMDV), bovine rotavirus, bovine viral diarrhea virus, bluetongue virus, 
and bovine papillomavirus. Of these viruses, foot-and-mouth disease virus (FMDV) has been 
addressed majorly as livestock is an inevitable part of the economy. Livestock productivity 
is compromised due to frequent occurrence of foot-and-mouth disease (FMD). Vaccination 
is one of the main strategies to control foot-and-mouth disease. Yet, lack of high-quality and 
effective vaccine in Pakistan warrants the development of genotype-matched vaccines. One 
of the approaches to develop such vaccines is reverse genetics that is very costly and labori-
ous. This demands exploring other alternative approaches. Of the alternative approaches, 
engineering edible plants with the pathogenicity-causing genes is more promising.
An oral vaccine against FMDV was developed by expressing structural protein VP1 in trans-
genic Stylosanthes guianensis [52]. In these experiments, the level of recombinant protein was 
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varied from 0.1 to 0.5% of total soluble protein. These levels were enough to induce a protec-
tive systemic antibody response in mice. In another attempt, capsid precursor polypeptide 
(P1) was expressed in rice, and 0.6–1.3 mg/g of TSP was observed that induced a protective 
immune response in mice [53]. Further, in mice when vaccinated orally, FMDV-specific muco-
sal immune responses were detected. However, partial virus clearance after challenge was 
observed. To address these low-expression problems, chloroplast transformation approach 
can be used. In a study, VP1 was expressed in tobacco chloroplasts and 2–3% values were 
recorded [54]. In another study, epitopes (B cell) of structural proteins VP1 and VP4 and of 
nonstructural proteins 2C and 3D (T cell) were produced in N. benthamiana plants using a 
plant virus expression system [55]. More recently, tandem-linked VP1 proteins of two sero-
types, A and O, are expressed in forage crop Crotalaria juncea and fed to guinea pigs that 
produced humoral as well as cell-mediated immune responses [56]. From all these studies 
and experiments being carried out in the laboratory of the author of this chapter demonstrate 
that plant-based overexpression of antigenic proteins to control FMDV is an effective way but 
needs further experimentation to improve efficacy of edible vaccines by engineering epitopic 
proteins with different adjuvants (Khan MS, unpublished).
5. Conclusions
Nuclear transformation, achieved using microprojectile bombardment or Agrobacterium 
strains, is predominantly carried out to tailor agronomic traits in crops. However, this technol-
ogy is not successful to transform upland cotton where cells are recalcitrant to regeneration, 
despite genome mixing through crosses between different genotypes. Biotechnologists rely on 
this technology though genes escape and pollinate other related crops or weeds, developing 
weeds or super weeds, respectively. An alternate strategy to develop transgenics is the chloro-
plast transformation technology since this technology offers natural gene containment, high-
level transgene expression with bona fide structures of proteins, and allows all transformation 
events to be uniform as far as gene integration into the plastome is concerned. High-level 
gene expression is due to the polyploid nature of chloroplasts in a cell and of plastomes in 
each chloroplast, biologically active proteins are due to the presence of chaperon proteins, and 
uniform integration of transgenes into the plastome is due to the homologous recombination. 
Hence, chloroplast transformation is more suitable for expression of health-related traits in 
plants rather agronomic in crops. In either case, transgenics should be grown in the field fol-
lowing approved biosafety guidelines and strict stewardship.
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